PharmaCyte announces encapsulation of live cells for clinical trial in pancreatic cancer
PharmaCyte announced that partner Austrianova has successfully encapsulated the live cells used in PharmaCyte’s therapy for its clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer. The cells are now growing and dividing inside the Cell-in-a-Box® capsules. January 15, 2019